ISPE

SEPTEMBER 29, 2023

While it is very energy-consuming to produce these therapies, Takeda paid special attention to the facility’s design to optimize the processes and to make them, and the site, as energy efficient as possible in keeping with their commitment to minimize environmental impact and progress towards future sustainability goals.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Patient Care 52

European Pharmaceutical Review

JULY 15, 2022

A deep carbon footprint is a common hallmark of energy intensive manufacturing processes – and the manufacture of pharmaceuticals is no exception. However, emissions levels can be reduced by adopting a sustainable approach to process efficiency, energy generation and energy procurement. Formulating a sustainable energy strategy.

Pharmaceutical Companies 92

Pharmaceutical Companies Pharmaceutical Companies 92

ISPE

MARCH 14, 2023

Management of single-use products after use is important to most manufacturers and many have established sustainability goals for the immediate future. Management of these complex items can be a challenge. The Disposables CoP received feedback from small to large firms (>1000 employees) in a survey of the industry’s manufacturers.

Packaging 98

Packaging Communication 98

ISPE

SEPTEMBER 8, 2022

Many of these requirements include adhering to global regulatory harmonization, improving supply chain robustness, minimizing drug shortages, reducing the complexity of managing product life cycles, and reducing the environmental impact of pharmaceutical processes. The industry is continuously evolving to meet new requirements.

Packaging 93

Packaging FDA 93

ISPE

FEBRUARY 17, 2023

Key among these included a presentation by the director of FDA’s CBER on cell and gene therapy manufacturing and a range of considerations behind new facility planning from a Janssen Pharmaceuticals executive whose company has been paving the road ahead with its facilities. The facility does a lot of multivariate analysis.

FDA 98

FDA Vaccines 98

European Pharmaceutical Review

MARCH 7, 2024

Last month, construction began on Europe’s first industrial-scale facility dedicated to the production of lead-212 based radioligand therapies. What is the significance of ATLab (Alpha Therapy Laboratory) being Europe’s first industrial-scale facility dedicated to the production of targeted alpha therapies?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Immunization FDA 52

ISPE

JUNE 23, 2023

Next, attendees will learn about the time-to-market deployment of new manufacturing facility through the “hybrid-modular” method, which will also include case-studies about the lessons learned through the implementation process. Learn More & Register Facilities & Equipment Quality Adv Manuf QC Sustain

Pharmaceutical Companies 94

Pharmaceutical Companies Pharmaceutical Companies 94

Pharmaceutical Technology

OCTOBER 13, 2022

Estimates suggest UK businesses will squander £30bn of energy in 2022 – even as, over the past year, the case for efficiency has become more urgent. War in Ukraine created bitter headwinds in energy markets, and businesses are being buffeted. Energy efficiency is a commercial as well as an environmental imperative.

Hospitals 52

Hospitals 52

Hospital Pharmacy Europe

DECEMBER 13, 2023

Biological drugs are playing an increasingly important role in the management of multiple health conditions, but, to date, the innovations have only scratched the surface of their potential. However, formulating drugs for these devices typically requires a lot of energy and, therefore, heat as well as solvents.

Hospitals 98

Hospitals Dosage Compounding Vaccines 98

Pharmaceutical Technology

FEBRUARY 24, 2023

In some cases, the rising cost of capital will cause firms to restrict plans to upgrade their facilities. In an interview with the Financial Times, financial consultancy practice NextWealth’s managing director Heather Hopkins said: “Higher interest rates may indeed prove challenging for private equity-backed consolidators.

59

59

European Pharmaceutical Review

JULY 21, 2023

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. Globalisation and supply chain complexity are a factor.

Vaccines 95

Vaccines FDA Communication Hospitals 95

pharmaphorum

JANUARY 6, 2021

In 2018, we were preparing to build a European facility to produce individualised cell therapies for the treatment of cancer. In my experience, completing the design and build of a facility such as this, through to qualification, licence and becoming fully operational, would normally take four to five years.

Hospitals 119

Hospitals Communication 119

ISPE

FEBRUARY 7, 2023

™, emerging technologies, and facility design and construction. For the latter two, some medications can be combined for cardiovascular treatment with less frequent dosages, which helps ensure older patients who may struggle more with maintaining a drug taking schedule receive the medications needed to manage the condition.

Vaccines 88

Vaccines Dosage Hospitals 88

pharmaphorum

OCTOBER 31, 2022

Sen (pictured above) was barely in the new role before activist hedge fund Elliott Investment Management took what is reported to be a “substantial” stake in the group a couple of weeks ago, with market watchers now waiting to see if it will agitate for change.

Hospitals 59

Hospitals 59

European Pharmaceutical Review

AUGUST 31, 2023

Usually consisting of an injected medical radionuclide and a target molecule, radiopharmaceuticals precisely bind to tumours, destroying tumour cells with a high linear energy transfer from radionuclide decay, thus, halting tumour growth. Long production times and high energy costs in manufacturing are additional considerations.

Hospitals 79

Hospitals FDA Chemotherapy 79

pharmaphorum

SEPTEMBER 9, 2022

In addition, 10 of the biggest names have signed up to a renewable energy initiative that aims to decarbonise the supply chain and increase access to renewables. It should be granular enough for asset-level insights, whether those assets be managed directly or by a supplier, and broad enough to inform company-level operational decisions.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Vaccines 105

pharmaphorum

MAY 10, 2022

Jamie Phares, managing director, The Janssen Pharmaceutical Companies of Johnson & Johnson in the Gulf Cooperation Council (GCC), talks about how the healthcare industry needs to come together to reduce its environmental impact and further protect public health. Across the healthcare ecosystem, we all play a part. About the author.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

pharmaphorum

AUGUST 24, 2020

She served as the Deputy Director (Acting) in the Office of Process and Facilities (OPF)/OPQ/CDER, responsible for new, generic, and biologic drug product quality review and facility assessment. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.

Compounding 52

Compounding FDA Immunization 52

pharmaphorum

MARCH 10, 2022

Investing in biological production facilities. Flexibility will be even more important in the field of rare diseases due to the challenge of managing small volumes while ensuring high-quality standards. Reducing the environmental impact of biopharmaceutical production is just one piece of the sustainability puzzle for the Chiesi Group.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Packaging Immunization 98

ISPE

JULY 10, 2023

As such, many of our facilities’ engineering groups started to conduct surveys to benchmark ventilation energy use, with the goal to improve the energy efficiency of HVAC systems by reducing air change rates (ACRs). link] Energy conservation has been a top priority in our GHG emissions reduction strategy. 3 1 Ahearn, J.,

Documentation 52

Documentation FDA 52

ISPE

AUGUST 1, 2023

Choose from regulatory excellence in the "Workshop on ICH Q9(R1) Quality Risk Management," gain practical wisdom in contamination control strategies with the "Development of a Contamination Control Strategy (CCS)," or elevate your leadership acumen in the "Essentials for Leadership Development."

52

52

ISPE

NOVEMBER 1, 2022

All of this energy has been channeled by the International Board into a rewriting of the ISPE Strategic Plan for 2023–25 with a “more confident position: Shaping the Future of Pharma.”. Kopcha calls this a standard definition of quality, but adds that quality is what gives patients confidence in their next dose of medicine.

FDA 98

FDA Insurance Chemotherapy Documentation 98

PharmaShots

JUNE 29, 2023

The company's value chain includes collecting krill in the Antarctic and supplying it to customers across the world through their Montevideo Logistics Hub and Houston Production Facility. General Health, Immune, Cardiovascular, Digestive, Personal Care, and Weight Management are among the categories under which the company operates.

Immunization 40

Immunization 40

European Pharmaceutical Review

JANUARY 31, 2024

A combination of four 4,000-litre single-use bioreactors reaching a 16,000-litre scale has resulted in the successful completion of WuXi Biologics’ first manufacturing run at its drug substance facility MFG7 in Ireland. “We are excited to achieve this milestone for the Ireland facility.

83

83

The People's Pharmacy

APRIL 17, 2023

We were astonished to see Dr. Woodcock’s testimony to the House Subcommittee on Energy and Commerce. reliance on these countries for APIs is increasing, “Only 28 percent of facilities making APIs for the U.S. For most of that time the FDA has reassured us that generic drugs are just fine, thank you very much.

FDA 66

FDA Insurance 66

Pharmaceutical Technology

APRIL 28, 2023

At its Biocon Park campus in Bengaluru the company set up and commissioned a new microbial cGMP facility and expanded its mammalian cell manufacturing facility Meanwhile, Bristol Myers Squibb (BMS), one of the world’s largest pharmaceutical companies, celebrated 25 years of collaboration with Syngene in March 2023.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies 52

Fuld

APRIL 24, 2022

Until now, financial institutions offered only traditional services, such as banking activities and trading facilities. Crowd financing renewable energy projects in Austria and Switzerland are also a huge milestone. However, when conventional finance converges with technology, it unleashes vast opportunities.

Grocery Stores 52

Grocery Stores Insurance 52

ISPE

OCTOBER 31, 2022

Relive the Magic of the 2022 Facility of the Year Awards (FOYA) Banquet! Relive the Magic of the 2022 Facility of the Year Awards (FOYA) Banquet! FOYA is about innovation, creativity, and facility design.” CRISPR won the award for creating a flexible, digitally-enabled facility that brings the promise of innovation to life.

Vaccines 52

Vaccines Packaging 52

ISPE

OCTOBER 31, 2022

More than 200 people celebrated the 2022 Facility of the Year Award Winners at a reception and banquet Sunday night at the 2022 ISPE Annual Meeting & Expo at the Gaylord Palms in Orlando, Florida. FOYA is about innovation, creativity, and facility design.” The manufacturing facility was designed thoughtfully and innovatively.

Vaccines 52

Vaccines Packaging 52

ISPE

OCTOBER 31, 2022

More than 200 people celebrated the 2022 Facility of the Year Award Winners at a reception and banquet Sunday night at the 2022 ISPE Annual Meeting & Expo at the Gaylord Palms in Orlando, Florida. FOYA is about innovation, creativity, and facility design.” The manufacturing facility was designed thoughtfully and innovatively.

Vaccines 52

Vaccines Packaging 52

pharmaphorum

MARCH 25, 2022

Jazz Pharma has started construction of a manufacturing facility in the UK that will be used to manufacture cannabinoid drugs from its recently acquired GW Pharma subsidiary. facility at Kent Science Park (KSP) in Sittingbourne is due to open in 2024, and when fully operational will create more than 100 new highly skilled jobs.

Chemotherapy 98

Chemotherapy 98

Board Vitals - Pharmacist

NOVEMBER 1, 2022

As physicians, we make decisions every day about how to prioritize our time, energy, focus, attention, and money. The way they turn complicated topics into more easily manageable problems is extremely helpful.” – mmcfaddin. Guests will range from large hospital system CEOs to clerical/facilities staff and everyone in between.

Medical Schools 52

Medical Schools Insurance Hospitals 52

PharmaShots

MAY 10, 2023

The company works through its three franchises of Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. In Sep 2022, Olympus launched Thunderbeat, an Open Fine Jaw Type X surgical energy device for laparoscopic and open surgery across Japan. Smith + Nephew’s revenue spiked by 0.05% in 2022 as compared to 2021.

Nursing Homes 40

Nursing Homes Hospitals FDA Communication 40

Pharmaceutical Technology

MARCH 22, 2023

Various uses soon became apparent including those for supply chain management, anti-counterfeiting, and to improve patient safety. The aim was to streamline workflows in healthcare facilities by reducing error-prone manual data entry for every customer. Using GS1 standards allows us to do just that.”

Labelling 105

Labelling Data Entry Communication FDA 105

ISPE

SEPTEMBER 11, 2023

Herein, DM refers to a manufacturing model in which many units or facilities are disseminated across different geographical areas 6 , 7 DM facilities may produce similar or identical products under a unified pharmaceutical quality system (PQS) or operate as independent units with different outputs.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

Pharmaceutical Technology

JULY 8, 2022

A VDR should already have the following key embedded functionality: secure, encrypted file transfer and storage, information rights management to provide fine-grained user access, collaboration tools such as online Q&A, sophisticated audit trails and reporting, and integration capabilities with other third-party document management systems.

Documentation 52

Documentation 52

ISPE

MARCH 6, 2023

For example, currently, every 1 kg of small molecule active ingredient can take more than 100 kg of materials to produce, requiring huge facilities for production and waste disposal, as well as long lead times. while meeting patient needs as a primary goal.

Communication 52

Communication Patient Care 52